Browsing publications by Dr Ross Maxwell

Newcastle AuthorsTitleYearFull text
Hua Lin
Waseema Patel
Val Affleck
Professor Doug Turnbull
Abhishek Joshi
et al.
Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells2017
Dr Ross Maxwell
Professor James Wason
Imaging biomarker roadmap for cancer studies2017
Carlo Bawn
Martin Galler
Huw Thomas
Suzanne Kyle
Professor Nicola Curtin
et al.
PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS2017
Dr Ross Maxwell
Professor Andrew Blamire
A new paramagnetically shifted imaging probe for MRI2016
Dr Michael Firbank
Dr Alison Yarnall
Dr Rachael Lawson
Dr Gordon Duncan
Dr Tien Kheng Khoo
et al.
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study2016
Emma Haagensen
Huw Thomas
Dr Ross Maxwell
Professor Herbie Newell
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-0372016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Jill McKenna
Dr Piotr Pieniazek
et al.
Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study2016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Dr Piotr Pieniazek
Dr Rakesh Heer
et al.
Evaluation of early responses to neoadjuvant chemotherapy in muscle-invasive bladder cancer using a dynamic contrast-enhanced MRI and diffusion-weighted MRI: MARBLE study2016
Emma Haagensen
Huw Thomas
Dr Ross Maxwell
Professor Herbie Newell
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent2016
Dr Britta Vormoor
Henrike Knizia
Michael Batey
Dr Petra Dildey
Abhishek Sharma
et al.
Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging2014
1234